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Abstract
Due to their similarity to natural counterparts, nucleic acid derivatives (nucleobases, nucleosides, and nucleotides, among
others) are interesting molecules for pharmaceutical, biomedical, or food industries. For this reason, there is increasing
worldwide demand for the development of efficient synthetic processes for these compounds. Chemical synthetic meth-
odologies require numerous protection-deprotection steps and often lead to the presence of undesirable by-products or
enantiomeric mixtures. These methods also require harsh operating conditions, such as the use of organic solvents and
hazard reagents. Conversely, enzymatic production by whole cells or enzymes improves regio-, stereo-, and
enantioselectivity and provides an eco-friendly alternative. Because of their essential role in purine and pyrimidine
scavenging, enzymes from purine and pyrimidine salvage pathways are valuable candidates for the synthesis of many
different nucleic acid components. In recent years, many different enzymes from these routes, such as nucleoside phos-
phorylases, nucleoside kinases, 2′-deoxyribosyltransferases, phosphoribosyl transferases, or deaminases, have been suc-
cessfully employed as biocatalysts in the production of nucleobase, nucleoside, or nucleotide analogs. Due to their great
activity and stability at extremely high temperatures, the use of enzymes from thermophiles in industrial biocatalysis is
gaining momentum. Thermophilic enzymes not only display unique characteristics such as temperature, chemical, and pH
stability but also provide many different advantages from an industrial perspective. This mini-review aims to cover the
most representative enzymatic approaches for the synthesis of nucleic acid derivatives. In this regard, we provide detailed
comments about enzymes involved in crucial steps of purine and pyrimidine salvage pathways in thermophiles, as well as
their biological role, biochemical characterization, active site mechanism, and substrate specificity. In addition, the most
interesting synthetic examples reported in the literature are also included.
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Introduction
Nucleic acids are indispensable molecules for all living organ-
isms, since they are essential for many different biochemical
processes involving storage and transfer of genetic informa-
tion. In this respect, the use of nucleic acid derivatives (ana-
logs of nucleosides, nucleotides, or nucleobases) as active
pharmaceutical ingredients (APIs) is extensively reported in
the literature (De Clercq 2005; Galmarini et al. 2002;
Jordheim et al. 2013; Lapponi et al. 2016; Parker 2009).
Additionally, some nucleoside-5′-monophosphates (NMPs)
are also commonly used in the food industry. For example,
inosine monophosphate (IMP) and guanosine monophosphate
(GMP) have been found to elicit an umami taste in humans
(Behrens et al. 2011). Moreover, growth and immune system
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development in babies are improved by dietary nucleotide
supplementation (Hawkes et al. 2006). Moreover,
deoxynucleoside-5′-triphosphates (dNTPs) are extensively
used as reagents in a wide range of molecular biology appli-
cations, such as DNA amplification, real-time PCR, DNA
sequencing, DNA microarray experiments, and site-directed
mutagenesis, among others. As a result, there is a significant
demand for nucleic acid derivatives in food, biomedical, and
pharmaceutical industries, and therefore, many different re-
search groups and companies are focused on the development
of innovative and efficient synthetic processes.
Traditionally, these molecules have been synthesized by
different multi-step chemical methods employing harmful sol-
vents and reagents (Mikhailopulo 2007), leading to poor or
moderate yields and low product purity. Nowadays, enzymat-
ic or chemoenzymatic production by whole cells or enzymes
offers an environmentally friendly alternative to traditional
chemical processes. They also have many advantages, such
as one-pot one-step reactions, high stereo- and regioselec-
tivity, and the absence of undesirable by-products (Boryski
2008; Del Arco and Fernández-Lucas 2017; Fernández-
Lucas 2015; Fresco-Taboada et al. 2013; Lapponi et al.
2016; Lewkowicz and Iribarren 2006, 2017; Mikhailopulo
2007, Mikhailopulo and Miroshnikov 2010).
Despite the advantages of enzyme-mediated bioconver-
sions, several factors hinder their industrial application: (i)
the low stability and short lifespan of the enzyme under the
rather harsh operating conditions often needed in some indus-
trial processes, (ii) the high cost of purification of recombinant
enzymes, (iii) the poor solubility of some organic substrates in
aqueous media, and (iv) difficulties associated to the isolation
of the biocatalyst from the reaction medium for reutilization.
To develop more efficient and economical processes, the
modern industry increasingly demands new biocatalysts
which exhibit activity and stability under aggressive reaction
conditions, e.g., extreme pH values, high temperatures, or
presence of organic solvents. In this context, enzymes from
extremophilic organisms are valuable biocatalysts for the in-
dustrial implementation of synthetic bioprocesses (Dumorne
et al. 2017; Raddadi et al. 2015; Van Den Burg 2003).
Thermophiles are organisms which can grow at high tem-
peratures, and they can be classified into three different
groups: moderate thermophiles (optimal growth from 45 to
70 °C), extreme thermophiles (optimal growth > 70 °C), and
hyperthermophiles (optimal growth from 80 to 110 °C)
(Zeldes et al. 2015). Enzymes from thermophilic microorgan-
isms, also known as thermozymes, are typically stable and
active at high temperatures. Therefore, the use of
thermozymes offers the possibility of raising the temperature
of the reaction and this helps to prevent microbial contamina-
tion, improves substrate solubility, and leads to reduced vis-
cosity in the reaction mixture. As a consequence, substrate
diffusion is increased, and higher overall reaction rates are
obtained. Additionally, the production of thermozymes using
mesophilic organisms as host strains reduces the difficulty and
costs of the purification process. For example, a heat shock
treatment can be used to denature most of the mesophilic
proteins in the cleared lysates, avoiding tedious multi-step
purification processes (Del Arco et al. 2017a, b, c; Haki and
Rakshit 2003).
Interestingly, pairwise and multiple sequence alignment, as
well as functional and structural comparison between
mesophilic and thermophilic enzymes reveal that both, ther-
mophilic and mesophilic enzymes, display similar domain
organization, catalytic mechanisms, and active site architec-
tures (Vieille and Zeikus 2001). Taking into an account all
aforementioned advantages (easier purification and crystalli-
zation, similar activity, and higher thermal stability than
mesophilic counterparts, among others), thermostable en-
zymes have also played a key role as structural models for a
better understanding of molecular mechanisms about
structure-function relationship in the enzyme families
(Vieille and Zeikus 2001).
Purine and pyrimidine metabolism are essential metabolic
routes in all living organisms, because nucleobases are key
molecules for the synthesis of DNA and RNA, proteins, and
other metabolites. Biosynthesis of nucleotides is performed
through two different metabolic routes: de novo and salvage
pathways. Most organisms synthesize purine and pyrimidine
nucleotides from simple precursors like glycine, glutamine, or
aspartate (de novo pathway). Meanwhile, in salvage path-
ways, the requirement for nucleobases is satisfied by means
of different metabolic routes with endogenous and/or exoge-
nous sources of preformed nitrogen bases. Therefore, many
different enzymes from purine and pyrimidine salvage path-
ways can be employed in the synthesis of nucleic acid deriv-
atives. In fact, these natural enzymatic schemes have been
reproduced in industry.
Purine salvage pathway
Purine salvage is an essential mechanism for the recovery of
purine nucleobases in organisms (Fig. 1). Because de novo
pathways for purine synthesis are absent in the majority of
parasites, enzymes involved in purine salvage have become
attractive therapeutic targets for the design of inhibitors against
parasitic diseases (Del Arco and Fernández-Lucas 2017; El
Kouni 2003). Consequently, scientific reports on the functional
and structural characterization of these enzymes have provided
a lot of valuable information about their substrate specificity
and reaction mechanism(s). Because of this, many different
enzymes from these metabolic pathways, such as purine nucle-
oside phosphorylases (PNPs), nucleoside kinases (NKs), purine
phosphoribosyltransferases (purine PRTs), deaminases (DA),
and nucleoside 2′-deoxyribosyltransferases (NDTs), have been
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successfully employed as biocatalysts for the synthesis of
nucleic acid components. As a consequence, the search for
these types of enzymes in thermophilic microorganisms is
now the main goal of many different research projects.
Purine nucleoside phosphorylases (PNPs)
PNP (EC 2.4.2.1) belongs to the family of nucleoside phos-
phorylases (NPs) (Bzowska et al. 2000; Lewkowicz and
Iribarren 2006; Pugmire and Ealick 2002). PNP catalyzes
the reversible phosphorolysis of the C–N glycosidic bond of
nucleosides and 2′-deoxynucleosides to generate ribose- or
deoxyribose-1-phosphate along with the corresponding purine
nucleobase (Pugmire and Ealick 2002) (Fig. 2). It is a key
enzyme in the purine salvage pathway, being responsible for
the recovery of purine bases from endo- and/or exogenous
sources.
According to their oligomeric state, two different forms of
PNPs have been identified: low-molecular-mass PNPs with
trimeric quaternary structure and high-molecular-mass PNPs,
which are hexamers. Trimeric PNPs are strictly specific for 6-
oxopurine nucleosides (i.e., inosine, guanosine, and deriva-
tives) and bases (i.e., hypoxanthine, guanine, and derivatives),
whereas hexameric PNPs can only recognize 6-oxo and 6-
aminopurine derivatives. Trimeric PNPs usually originate
from mammals and higher organisms, while hexameric
PNPs are more common in bacteria and protozoan
(Lewkowicz and Iribarren 2006; Yehia et al. 2017). For this
reason, bacterial and protozoan PNPs have been studied as
therapeutic targets for the treatment of parasitic diseases such
asmalaria, leishmaniasis, Chagas disease, or sleeping sickness
(Berg et al. 2010; El Kouni 2003).
PNPs display a high promiscuity in substrate recognition
and can act on many different nucleobase and nucleoside an-
alogs. However, regarding ribose moiety recognition, PNPs
are highly specific for ribonucleosides and display low activ-
ity values when 2′-deoxynucleosides or 2′, 3′, or 5′ modified
nucleosides (Fig. S1) are employed as glycosyl donors
(Lewkowicz and Iribarren 2006; Yehia et al. 2017).
Consequently, different protein engineering strategies, such
as site-directed mutagenesis and directed evolution, have been
tried out in attempts to improve the recognition of ribose moi-
ety variants, e.g., 3′-deoxynucleosides, 5′-modified nucleo-
sides, 2′,3′-dideoxynucleosides, 2′-arabinosyl nucleosides, or
Fig. 1 Purine salvage pathway in Haloferax volcanii (Stuer-Lauridsen
and Nygaard 1998). NK, nucleoside kinase; MTAP, S-methyl-5′-
thioadenosine phosphorylase; Gua-DA, guanine deaminase; Ado-DA,
adenosine deaminase; Gua-DA, guanine deaminase; APRT, adenine
phosphoribosyltransferase; HGPRT, hypoxanthine-guanine
phosphoribosyltransferase; S-AMP lyase, succinyladenylate lyase; S-
AMP synth, succinyladenylate synthetase; GMP reductase, guanosine-
5′-monophosphate reductase; IMP dehyd, inosine-5′-monophosphate de-
hydrogenase; GMP synth, guanosine-5′-monophosphate synthetase
Fig. 2 Catalytic mechanism of human PNP (Pugmire and Ealick 2002)
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halogenated 2′-deoxynucleosides (Fig. S1) (Birmingham et al.
2014; Lewkowicz and Iribarren 2006; Yehia et al. 2017).
Due to the wide range of substrates they accept and the
possibility of using them in combination with other enzymes
such as kinases (NK) or pyrimidine nucleoside phosphory-
lases (PyNP), PNPs have been extensively employed in the
synthesis of modified nucleosides and nucleotides
(Lewkowicz and Iribarren 2006; Yehia et al. 2017;
Fernández-Lucas 2015). Considering the advantages of the
thermophilic enzymes, in recent decades several research
groups have focused on the search for NPs from thermophilic
strains.
Okuyama et al. (1996) purified and characterized a trimeric
PNP (which they named PNP I) and a PyNP from Bacillus
stearothermophilus TH 6-2. Likewise, they applied isolated
NPs to the enzymatic phosphorolysis of inosine and guano-
sine (PNP I) or thymidine and uridine (PyNP). In 1997, the
same authors cloned, expressed, and purified the recombinant
PNP I and PNP II from B. stearothermophilus (Hamamoto et
al. 1997a, b). This second PNP displays a substrate specificity
different from that of PNP I, acting more efficiently towards
adenosine than on other nucleosides. The presence of two
different PNP genes encoded in B. stearothermophilus ge-
nome suggests that the expression levels of both enzymes
could be regulated by intracellular nucleoside concentrations.
A well-known strategy to synthesize nucleosides is the
transglycosylation reaction carried out by two NPs. Thereby,
the combined use of PyNP and PNP in one-pot, two-step
reactions to produce purine nucleosides from pyrimidine nu-
cleosides, or vice versa, is frequently used as a synthetic strat-
egy (Fig. 3).
Hori et al. (1991) developed a one-pot, two-step process for
the enzymatic production of 5-methyluridine from inosine and
thymine by employing co-immobilized PNP and PyNP from B.
stearothermophilus JTS 859 in a sequential reaction. A similar
approach was used by Taran et al. (2009) by combining partial-
ly purified preparations of PNP II and PyNP from Geobacillus
stearothermophilus B-2194 (basonym B. stearothermophilus)
covalently attached to aminopropylsilochrom AP-CPG-170.
Immobilized derivatives exhibited high enzymatic activity and
stability at 70 °C andwere reused up to 20 times in the synthesis
of 2′-deoxyadenosine. Finally, as a proof of concept,
immobilized biocatalysts were used in the enzymatic synthesis
of several APIs, such as 2-chloro-2′-deoxyadenosine
(cladribine, anti tumoral FDA drug), 2-fluoro-2 ′-
deoxyadenosine (prodrug used in suicide gene therapy in can-
cer treatment), and arabinosyl adenine (vidarabine, ara-A, an
FDA-approved drug for the treatment of herpes simplex and
varicella zoster viruses, and a potential precursor of fludarabine
and clofarabine, FDA-approved drugs for cancer treatment).
Trelles et al. (2005) carried out a microbial screening to
find transglycosylation activities in a microorganism library
of more than 30 microorganisms. As a result , B.
stearothermophilus ATCC 12980 was chosen as the best bio-
catalyst for the enzymatic production of different 6-substituted
purine nucleosides, such as 6-chloropurine, 6-methoxypurine,
6-mercaptopurine, and 6-iodopurine ribonucleosides.
Furthermore, B. stearothermophilusATCC 12980 whole cells
were immobilized in different matrices, such as agar, agarose,
and polyacrylamide and efficiently employed in the synthesis
o f d i f f e r en t 6 - subs t i t u t ed pu r i ne r ibo and 2 ′ -
deoxyribonucleosides from uridine or thymidine at different
reaction times (1–24 h) with a conversion percentage ranging
from 29% (6-iodopurine riboside) to 96% (6-aminopurine
riboside) (Trelles et al. 2005). More recently, the synthesis of
anti-HCV compounds has been carried out using G.
stearothermophilus (basonym B. stearothermophilus) whole
cells (Rivero et al. 2012). In this work, the authors tested the
ability of G. stearothermophilus CECT 43 as a biocatalyst for
the synthesis of different 6-halogenated purine ribo and 2′-
deoxyribonucleosides. The authors also tested different reac-
tion parameters, such as molar ratio, temperature, and reaction
time. Moreover, to evaluate the potential of this microorgan-
ism as an industrial biocatalyst, G. stearothermophilus CECT
43 whole cells were immobilized by entrapment in 2–5% (w/
v) agarose and 15–25% (w/v) polyacrylamide. In view of the
results obtained, agarose at 4% was selected as the best option
for the immobilization process. The immobilized derivative
was shown to be active and stable for 6 months (when stored
at 4 °C) and reusable during 70 cycles, leading to a production
of 379 mg/L of 6-chloropurine-2′-deoxyribonucleoside.
In 2004, Tahirov et al. (2004) solved the three-dimensional
structure of PNP from Thermus thermophilus HB8 (TtPNP)
and shed light on its unusual substrate specificity. Although
the TtPNP structure seems to be similar to those of hexameric
PNPs (e.g., PNPs from Escherichia coli) and should also bind
6-oxo and 6-aminopurines, functional characterization re-
vealed a strict specificity for guanosine (similar to trimeric
PNPs), and no activity was observed on adenosine (Fig. 4).
The reason of this unexpected specificity for guanosine could
Fig. 3 Transglycosylation




be different interaction between Asn204 and Glu156 residues
and corresponding nucleobase. When TtPNP binds adenosine,
the nucleobase is mainly recognized by Asn204 residue and
reaction evolves in unfavorable way, whereas when TtPNP
binds guanosine, Glu156 is the main residue involved in
nucleobase recognition and the reaction proceeds towards nu-
cleoside hydrolysis.
Interestingly, recent studies described the presence of a
second trimeric PNP in T. thermophilus HB8 (Tomoike et al.
2013). However, other studies suggest that it could be a mono-
mer in solution (Almendros et al. 2012). This novel PNP dis-
plays strict activity on adenosine, showing that T.
thermophilus PNPs have an atypical reversal substrate speci-
ficity when compared to that of their corresponding trimeric
and hexameric homologs (Bzowska et al. 2000; Lewkowicz
and Iribarren 2006; Pugmire and Ealick 2002).
In a very interesting study, Almendros et al. (2009) tested
several strains of T. thermophilus in their search for thermo-
stable biocatalysts for the synthesis of ribo and 2′-
deoxyribonucleosides. As a result, T. thermophilus HB27,
PRQ-16, PRQ-25, B, Fiji3A1, and VG7 were selected as the
most relevant candidates. Additionally, the reaction mixtures
did not show the presence of any by-products arising from to
the action of adenosine deaminases, a common problem in
mesophiles.
As a follow-up of this previous work, Almendros et al.
(2012) performed the cloning, expression, production, and
purification of recombinant PNP I and PNP II from T.
themophilus HB27. The biochemical characterization re-
vealed that both enzymes are active at extremely high temper-
atures (optimum activity at 95 °C) and display optimal activity
between pH 4–6. Analytical ultracentrifugation and substrate
specificity studies showed TtPNP I and TtPNP II as unusual
PNPs. One the one hand, TtPNP I was shown to be a
hexameric high-molecular-mass PNP with an atypical strict
specificity over 6-oxopurines, as expected from previous re-
ports (Tahirov et al. 2004). On the other hand, TtPNP II was
shown to be a monomeric low-molecular-mass PNP with a
remarkable preference for 6-amino and 2,6-diaminopurines.
Since no monomeric low-molecular-mass PNP has been re-
ported to date, TtPNP II represents the first milestone in this
respect (Almendros et al. 2012). Moreover, both enzymes
displayed a remarkable stability in the presence of organic
solvents, such as DMFA, DMSO, or 2-MeTHF, which are
usually employed to increase the solubility of some purine
bases and nucleosides.
In 2007, the production and characterization of a PNP from
the hyperthermophilic archaeon Pyrococcus furiosus (PfPNP)
was reported as the first archaeal PNP (Cacciapuoti et al.
2007). PfPNP is a hexamer, active and stable at extremely
high temperatures (optimum temperature at 120 °C, and Tm
ranging from 110 to 120 °C), with a very interesting resilience
to the presence of SDS. Despite the fact that PfPNP is a
homohexamer, this enzyme displays similar substrate speci-
ficity to that of trimeric mammalian PNPs which are specific
for guanosine and inosine. Furthermore, the results of site-
directed mutagenesis on Cys254 and Cys256 strongly sug-
gested that this Cys pair forms an intra-subunit disulfide bond
which plays an important role in the extremely high thermo-
stability of PfPNP.
By the same token, the production of thermostable PNPs
from Deinococcus geothermalis (DgPNP) and G.
thermoglucosidasius (GtPNP) was reported by Zhou et al.
(2013). In this exhaustive study, the authors analyzed the ther-
mostability, substrate specificity and kinetic properties of both
enzymes. Thermal studies revealed thatDgPNP was active and
stable at 55 °C for 8 h, whereasGtPNP was stable and active at
70 °C during the same time period. Similar to high-molecular-
mass PNPs, DgPNP and GtPNP recognized both 6-oxo and 6-
aminopurine nucleosides. Additionally, both enzymes were
tested against cytidine, 2′-deoxycytidine and 2′-amino and 2′-
fluoro modified nucleosides (Fig. S1). According to previous
experimental data, several fluoropurine nucleosides were pro-
duced by a multi-enzymatic PyNP-PNP system (Zhou et al.
2013). In this regard, the transglycosylation reaction catalyzed
by TtPNP and DgPNP (TtPyNP/DgPNP) led to the formation
of 2′-fluoro-2′-deoxyadenosine (24% conversion at 55 °C and
24 h). Moreover, the tandem reaction catalyzed by TtPyNP/
GtPNP led to the synthesis of 2′-fluoroarabinosyl adenine from
2′-fluoroarabinosyl uracil and adenine (14% conversion at
80 °C and 24 h).
Fig. 4 Overall structure of TtPNP (cartoon) in complex with guanosine
(sticks) (PDB access code 1ODJ). The probable hydrogen bonds are




MTAPs (EC 2.4.2.28) catalyze the reversible phosphorolysis
of 5′-deoxy-5′-methythioadenosine (MTA) in the presence of
inorganic phosphate (Fig. 5). Despite the fact that MTAP is an
essential enzyme in the metabolism of polyamines, it is also
important for the salvage of adenine, and many authors con-
sider MTAP to be part of the purine salvage pathway (Fig. 1).
Because of their similarity to PNPs, some authors suggest that
MTAPs may belong to the class of low- and high-molecular-
mass PNPs. Nevertheless, there is no consensus on this issue.
In 1994, the presence of a MTAP in the thermoacidophilic
archaeon Sulfolobus solfataricus (SsMTAP) was reported for
the first time (Cacciapuoti et al. 1994). SsMTAP displayed an
optimal activity at 120 °C, with negligible loss of activity
when incubated at 100 °C for 2 h, and a half-life of 5 and
15 min after incubation at 130 or 140 °C. In addition, the
enzyme showed stability and activity in the presence of some
denaturing agents (9 M urea, 4 M guanidine hydrochloride, or
0.075% SDS), organic solvents (negligible loss of activity in
presence of 50% v/v methanol, 50% v/v ethanol, or 50% v/v
dimethylformamide), and detergents (1% v/v Triton X-100)
when stored at room temperature for 24 h. In addition,
SsMTAP was shown not only to be capable of acting on
MTA but also to be active towards inosine, guanosine, and
adenosine, and its efficiency was higher than that of MTA.
SsMTAP was crystallized as a hexamer with three disulfide
bonds and this fact can account for its extreme thermal stabil-
ity (Appleby et al. 2001; Cacciapuoti et al. 1999).
More recently, Cacciapuoti et al. (2003) reported the pro-
duction, purification, and characterization of an MTAP from
the hyperthermohilic archaea Pyrococcus furiosus (PfMTAP).
As expected, the enzyme is active and stable at extremely high
temperatures (maximum activity at 125 °C, 98% of retained
activity after 5 h at 100 °C, and half-life of 43 min at 130 °C).
Furthermore, like SsMTAP, PfMTAP is a hexamer with a mo-
lecular mass of 180 kDa and is active using 5 ′-
methylthioadenosine, adenosine, inosine, and guanosine.
However, the kinetic analysis reveals that PfMTAP shows a
greater preference for 6-aminopurine nucleosides. PfMTAP is
also resistant to protein denaturant agents, such as detergents,
organic solvents, and salts, when stored at high temperature
(Cacciapuoti et al. 2003).
Interestingly, Cacciapuoti et al. (2005) discovered the pres-
ence of a second MTAP encoded in the genome of S.
solfataricus (SsMTAP II), which is strictly specific for MTA.
This finding suggests that SsMTAP II may not play a very
important role in purine scavenging in S. solfataricus.
Furthermore, these authors studied the substitution of several
Cys residues by site-directed mutagenesis and demonstrated
that they are essential for the enzyme stability.
Despite the great functional and structural knowledge of
thermophilic MTAPs, there are not many examples of their
use as biocatalysts in the literature. One interesting approach
was developed by Zhou et al. (2013). They cloned, produced,
purified, and also characterized the MTAP from hyperthermo-
phile Aeropyrum pernix (ApMTP). ApMTAP displayed high
activity at extremely high temperatures (> 99 °C) and was
stable for more than 69 h at 90 °C. To evaluate its substrate
specificity, kinetic analysis of phosphorolysis of inosine and
adenosine was performed in 50 mM phosphate, pH 7.0, at
80 °C. Results derived from these experiments showed aden-
osine to be the best substrate (lower KM and kcat values than
inosine). Finally, the authors performed the synthesis of 2′-
deoxy-2′-fluoroadenosine by employing a sequential
transglycosylation reaction catalyzed by TtPyNP and
ApMTAP at 80 °C and 24 h (yield 24%, 80 °C, and 24 h).
Purine phosphoribosyltransferases (purine PRTs)
Purine bases originating from the hydrolysis of nucleosides by
PNPs, MTAP, NHs, or NDTs (el Kouni 2003; Fresco-Taboada
et al. 2013; Schramm and Grubmeyer 2004) are used by pu-
rine PRTs to synthesize the corresponding NMPs. These en-
zymes catalyze the reversible transfer of the 5-phosphoribosyl
group from 5-phospho-α-D-ribosyl-1-pyrophosphate (PRPP)
to N9 in 6-amino or 6-oxopurines such as adenine, guanine,
hypoxanthine, and xanthine. A divalent metal ion, usually
Mg2+, is necessary for the transfer reaction. PRTs are essential
for purine scavenging because they are involved in the




formation and cleavage of the C–N glycosidic bonds in aden-
osine-5′-monophosphate (AMP), IMP, GMP, and xanthosine-
5′-monophosphate (XMP). All the abovementioned purine
PRTs display a conserved PRPP-binding motif (formed by a
13 residue Bfingerprint^ region), so they belong to the class of
type I PRTs (Del Arco and Fernández-Lucas 2017).
Nonetheless, as the enzymatic activity towards adenine differs
from that towards hypoxanthine, guanine, or xanthine, they
are also classified in terms of their substrate specificity. Thus,
6-aminopurine PRTs (APRTs) are specific for 6-aminopurines
(adenine, 2-fluoroadenine, or 2-chloroadenine, among others)
(Fig. S1) (Del Arco and Fernández-Lucas 2017; Del Arco et
al. 2017b; Esipov et al. 2016; Iglesias et al. 2015), while 6-
oxopurine PRTs (HPRT, GPRT, XPRT, HGPRT, and
HGXPRT) can use different 6-oxopurine bases (hypoxan-
thine, guanine, xanthine, and other 6-oxopurine analogs) as
substrates (Del Arco and Fernández-Lucas 2017; Scism et al.
2007, Scism and Bachmann 2010).
As mentioned above, adenine is the preferred substrate of
APRTs. However, this enzyme can recognize several 6-
aminopurine analogs (2,6-diaminopurine, 6-amino-2-
hydroxypurine, 6-methylpurine, zeatin, isopentenyladenine,
benzyladenine, and 8-azaadenine) as substrates (Fig. S1). In
spite of the mentioned substrate promiscuity, some examples
of the use of APRTs for the production of NMP analogs from
6-aminopurine derivatives have been published (Del Arco and
Fernández-Lucas 2017; Esipov et al. 2016).
Hansen et al. (2014) tested the biocatalytic potential of an
APRT from the thermoacidophilic archaeon S. solfataricus,
SsAPRT. This enzyme displays the highest activity at
pH 7.5–8.5; however, a distinct peak of activity at pH 4.5
was also noted. In a similar way, Del Arco et al. (2017b)
produced and biochemically characterized APRT from T.
thermophilus HB8, TtHB8APRT. TtHB8APRT was shown to
be active and stable in a pH range of 5–6, and in a temperature
range from 60 to 90 °C (optimal activity pH 6 and 70–80 °C).
More recently, the substrate specificity of an APRT from T.
thermophilus HB27 (TtHB27APRT) has been tested (Esipov et
al. 2016). TtHB27APRT displays activity towards different 6-
aminopurine derivatives, such as 2,6-diaminopurine, 2-
fluoroadenine, 2-chloradenine, 2-methoxyadenine, or N1-
methyladenine (Fig. S1). Interestingly, these authors also in-
clude a multi-enzymatic system composed of ribokinase gene
from Thermus sp. 2.9 and phosphoribosylpyrophosphate syn-
thetase (PRPP-synthetase) from T. thermophilus HB27 as the
PRPP source (Fig. 6). The production of 2-fluoroadenosine-
5′-monophosphate (≈ 37%) and 2-chloroadenosine-5′-
monophosphate (≈ 30%) fromD-ribose and the corresponding
nucleobase was carried out by this thermophilic cascade sys-
tem (Esipov et al. 2016)
In 6-oxopurine PRTs, the oligomerization state seems to
play a key role not only in catalysis but also in both stabiliza-
tion of the active conformation and overall protein stability.
Thermostable 6-oxopurine PRTs are described in the literature
as dimers and tetramers (Del Arco et al. 2017c, Del Arco and
Fernández-Lucas 2017; Hansen et al. 2014; Sinha and Smith
2001), as illustrated by dimeric HGXPRT from S. solfataricus
and tetrameric HGXPRT from T. thermophilus.
Purine PRTs are active over a broad variety of 6-oxopurine
bases; thus, some examples of the use of thermophilic 6-
oxopurine PRTs as biocatalysts for 5′-NMPs production have
b e e n r e p o r t e d . F o r e x am p l e , HGPRTs f r om
Thermoanaerobacter tengcongensis, TteHGPRT (Chen et al.
2003) and S. solfataricus, SsHGPRT (Hansen et al. 2014),
HGXPRT from Pyrococcus horikoshi, PhHGXPRT (de
Souza Dantas et al. 2008), and XPRT and HGXPRT from T.
thermophilus HB8, TtXPRT (Del Arco et al. 2017b, c) and
TtHGXPRT (Del Arco et al. 2017c, Del Arco et al. 2017c). It
is interesting to note the unusually high activity and stability
showed by TtHGXPRT under alkaline conditions (pH 8–11).
This allows it to be used for the synthesis of several dietary
nucleoside-5′-monophosphates, such as IMP and GMP, from
high concentrations of poorly water-soluble purine bases.
More recently, TtHGXPRT was covalently attached to
glutaraldehyde-activated MagReSyn®Amine magnetic mi-
crospheres (Del Arco et al. 2018a) (Fig. 7). Two different
approaches allowed the preparation of highly active
biocatalysts: (i) enzyme immobilization by the N-terminus at
pH 8.5 yielding MTtHGXPRT1-3 derivatives and (ii) a multi-
point covalent immobilization strategy through solvent-
exposed lysine residues at pH 10 (MTtHGXPRT4-5 deriva-
tives). As observed, the thermal stability and reusability of
magnetic derivative MTtHGXPRT3 was higher than that of
its magnetic counterpart MTtHGXPRT4-5. Accordingly,
MTtHGXPRT3 was used in the synthesis of ribonucleoside-
5′-monophosphates with an application as food additives.
More interestingly, Acosta et al. (2018) developed a multi-
enzymatic system for the one-pot production of nucleic acid
derivatives of interest in the pharmaceutical and food indus-
tries. Firstly, the 2 ′-deoxyribosyltransferase from
Lactobacillus delbrueckii , LdNDT, performed the
transglycosylation reaction using 2′-deoxyinosine or 2′-
deoxyguanosine as the 2′-deoxyribose donor and different pu-
rine analogs as acceptors, to get different modified nucleo-
sides (Fig. 8). In a second step, TtHGXPRT converted the
released hypoxanthine or guanine to IMP or GMP. As a result,
the combined use of LdNDTand TtHGXPRTshifted the equi-
librium of the transglycosylation reaction towards product
formation and transformed the resulting by-products into high
added-value compounds (Fig. 8).
Purine deaminases (DAs)
Deaminases catalyze the deamination process in molecules by
substituting the amino group for a keto group DAs from the
purine salvage pathway in extremophiles have not been
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studied extensively, with most research having been carried
out with those obtained from methanogens. For example,
Worrell and Nagle (1990) performed an extensive characteri-
zation of the purine salvage route in Methanobacterium
thermoautotrophicum. After studying the purine base and nu-
cleoside recycling reactions, adenine (EC 3.5.4.2) and adeno-
sine DA (EC 3.5.4.4) activities were detected. However, no
activity was reported for guanine DA (EC 3.5.4.3). Adenosine
deaminase was highly active inM. thermoautotrophicum, but
interconversion of adenine to hypoxanthine (adenine deami-
nase) was slightly detected. Likewise, the detection of phos-
phorylation products from adenosine, guanosine, and inosine
demonstrated the presence of nucleoside kinases. Moreover,
since adenosine deaminase activity was also much higher than
adenosine kinase activity, adenosine may be metabolized
through inosine to IMP.
Besides the deaminases from methanogens, Bauer and
Carlberg (1973) looked for enzymes with deaminase activity
in crude extracts of Halobacterium cutirubrum. Guanine, gua-
nosine, adenine, adenosine, and 2′-deoxyadenosine were tested
as substrates, and deaminase activity was exclusively detected
with the last two substrates. Particularly, an apparent preference
for deaminating 2′-deoxyadenosine instead of adenosine was
observed. Later on, further studies were carried out to
determine the substrate specificity for adenosine analogs. The
enzyme was able to deaminate 8-azaadenosine, whereas no
activity was detected for 6-chloropurineribofuranoside and 8-
aminoadenosine (Bauer and Carlberg 1973). These results
agree with those reported for both Halobacteirum volcanii
and Halobacterium halobium (Stuer-Lauridsen and Nygaard
1998) (Fig. 1). In this case, unlike inM. thermoautotrophicum,
the presence of an enzyme for guanine deamination was also
found. The authors suggested that in both halobacteria, adenine
is converted into adenosine by adenosine phosphorylase, which
later undergoes deamination to inosine by adenosine DA.
Finally, the guanine derived from guanosine catabolism is
transformed into xanthine by guanine deaminase (Stuer-
Lauridsen and Nygaard 1998).
Hermann et al. (2007) predicted the deaminase activity of
an unknown protein (Tm0936) from Thermotoga maritima
using theoretical chemistry methods. According to the relative
docking scores, this enzyme could be active on different aden-
osine derivatives (adenosine, S-adenosyl-L-homocysteine, or
5-methylthioadenosine). In a recent study, Hitchcock et al.
(2013) identified several Tm0936 homologs and predicted
possible binding substrates also by molecular docking. As a
result, adenosine, 5-methylthioadenosine, S-adenosyl-L-ho-
mocysteine, and 5′-deoxyadenosine were proposed as
Fig. 7 Schematic representation of immobilization of recombinant TtHGXPRT onto glutaraldehyde-activated MagReSyn®amino microspheres
Fig. 6 Synthesis of substituted adenosine-5′-monophosphates catalyzed by the TspRK/TtPPS/TtAPRTmulti-enzymatic cascade system (Esipov et al. 2016)
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substrates for these enzymes. Fortunately, after purifying the
enzymes, substrate specificity studies confirmed the structure-
based predictions.
Pyrimidine salvage pathway
Since the de novo pathway consumes more energy, the sal-
vage pathway is the one preferred to obtain pyrimidine nucle-
otides in some organisms. It incorporates free bases and nu-
cleosides from external sources while allowing the reutiliza-
tion of those obtained intracellularly from nucleotide turnover.
Finally, the pathway is involved in the synthesis of pentose
moieties and amino groups to be used as carbon and energy
sources and as a nitrogen source, respectively (Fig. 9). Due to
their importance in pyrimidine biosynthesis, pyrimidine sal-
vage enzymes have been extensively studied as attractive tar-
gets for rational drug design. Unfortunately, the scientific
community has made little effort to direct this extensive bio-
chemical knowledge towards synthetic applications.
Nucleoside kinases (NKs)
In the salvage pathway, phosphorylation of nucleosides
catalyzed by kinases allows nucleoside monophosphates
to be obtained from the corresponding ribonucleosides.
Because of this, kinases from the pyrimidine salvage path-
way may be interesting enzymes for the treatment of dif-
ferent human diseases. Elucidating the reaction mecha-
nisms for these enzymes would lead to a more accurate
targeting of pathogenic microorganisms (Chaudhary et al.
2013). In this respect, greater knowledge of the substrate-
binding mechanism would significantly aid the develop-
ment of new DNA base analogs applied to cancer treatment
(Galmarini et al. 2002; Jordheim et al. 2013).
Arnfors et al. (2006) solved the X-ray structure of a novel
NK from Methanocaldococcus jannaschii, MjNK. In addi-
tion, substrate specificity studies revealed a high promiscuity
in nucleobase recognition. In this regard, MjNK was able to
catalyze the phosphorylation of inosine, cytidine, guanosine,
and adenosine. More recently, NK activity was detected in
Thermoplasma acidophilum (Elkin et al. 2013). Ta0880 ki-
nase from Thermoplasma acidophilum, Ta0880NK, was pro-
duced and biochemically characterized, showing activity on
many different nucleosides and nucleotides (adenosine, gua-
nosine, inosine, cytidine, ATP, and GTP).
The uridine-cytidine kinase (EC 2.7.1.48, UCK) is a bot-
tleneck enzyme for pyrimidine scavenging and catalyzes the
phosphorylation of uridine and cytidine to UMP and CMP
(Tomoike et al. 2011, 2015). Additionally, the X-ray crystal
structure of this thermophilic enzyme has been solved, both
ligand-free and in complex with substrate analogs. Unlike
those from mesophilic organisms, UCK from T. thermophilus
displays a cytidine-limited substrate specificity and cannot
Fig. 8 Multi-enzymatic synthesis
of 2′-deoxynucleosides and
nucleoside-5′-monophosphates
by a coupled LdNDT/TtHGXRT
system
Fig. 9 The proposed pyrimidine salvage pathway in Thermus
thermophilus. CK, cytidine kinase; 5′-NT, 5′-nucleotidase; Cyd-DA,




bind uridine. Thus, in view of these results, this enzyme
should be renamed as TtCK instead of TtUCK.
Recent studies (Tanaka et al. 2016; Tomoike et al. 2011)
described the presence of an unusual amino acid (Tyr93) in the
active site of TtCK, while in other UCKs histidine (His) is
commonly found at this position. In view of this finding, the
authors suggested that the strict specificity for cytidine can be
attributed to this single residue. When Tyr93 was replaced by
histidine (Y93H) or glutamine (Y93Q), TtCK recovered the
phosphorolytic activity towards uridine. Conversely, when
Tyr93 was replaced by a smaller residue, such as Phe or
Leu, uridine could not be accepted by TtCK either (Tanaka
et al. 2016; Tomoike et al. 2011) (Fig. 10).
Thymidylate kinase (TMPK, EC 2.7.4.9) can be consid-
ered as a bridging enzyme between de novo and salvage path-
ways. In the de novo pathway, it catalyzes the ATP-Mg2+-
dependen t phosphory l a t ion of deoxy thymid ine
monophosphate (dTMP) to deoxythymidine diphosphate
(dTDP). Meanwhile, in the salvage pathway, TMPK is re-
sponsible for the conversion of thymidine to dTMP (Arnér
and Eriksson 1995). TMPK is active towards a broad range
of substrate analogs, and the resulting diphosphate analog is
incorporated into the newly synthesized DNA strand, which
leads to chain termination (Galmarini et al. 2002; Jordheim et
al. 2013). Because of this, TMPK serves as an attractive ther-
apeutic target for the development of antibacterial, antiparasit-
ic, and anticancer drugs. Therefore, it is not surprising that
many different crystal structures of TMPKs from
hyperthermophiles have been reported, such as those from
Sulfolobus tokodaii (Biswas et al. 2017) and T. thermophilus
(Chaudhary et al. 2013).
Pyrimidine nucleoside phosphorylases (PyNPs)
PyNPs are involved in the recovery of pyrimidine bases in
prokaryotic and eukaryotic organisms. In the same way than
their purine counterparts, PNPs and MTAPs, PyNPs catalyze
the cleavage of the glycosidic C–N bond in pyrimidine nucle-
osides through a reversible phosphorolytic mechanism, where
the Pi attacks the C-1′ position of the ribose moiety.
Depending on their substrate specificity, PyNPs can be sorted
into (i) uridine phosphorylases (UPs, EC 2.4.2.3), which dis-
play a remarkable preference for uracil nucleosides as sub-
strates and higher affinity for uridine than 2-deoxyuridine);
(ii) thymidine phosphorylases (TPs, EC 2.4.2.4), which show
a preference for thymidine as well as 5-substituted pyrimidine
nucleosides as substrates; and (iii) non-specific PyNPs (EC
2.4.2.2) (Lewkowicz and Iribarren 2006; Yehia et al. 2017).
UPs and TPs usually exist as hexamers and dimers, respec-
tively. Both PyNPs are found in higher organisms and some
bacteria such as E. coli. In contrast, PyNPs from lower organ-
isms are more promiscuous and can recognize both uracil and
thymine (deoxy)nucleosides. These general-purpose PyNPs
are usually homodimers.
Likewise, PyNP from thermophilic B. stearothermophilus
(BsPyNP) is formed by two identical subunits, exhibiting a
molecular weight of 46,271 Da (Okuyama et al. 1996). The
phosphorolytic reaction is carried out with both uridine and
thymidine, indicating that BsPyNP acts as a general-purpose
PyNP. In this regard, BsPyNP can use both uridine and thy-
midine, as well as their derivatives, as pentose-l-phosphate
donors for the synthesis of nucleoside analogs. It was later
reported that BsPyNP shares 41.5 and 38.1% sequence
Fig. 10 Tridimensional
representation of TtCK (cartoon)
complexed with cytidine-5′-
monophosphate (CMP) (sticks)
(PDB access code 3ASZ). Dot
lines represent hydrogen bonds
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identity with E. coli and human TP, respectively. In contrast,
no significant similarities were noted with E. coli uridine
phosphorylase (Okuyama et al. 1996; Tomoki et al. 1996).
In 2012, Almendros et al. (2012) characterized a homodi-
meric PyNP from T. thermophilus (TtPyNP), which was active
in a broad temperature range, even though it did not show
great thermostability. The activity decreased by half after 2 h
of incubation at 80 °C, probably due to the lability of the
interaction among bothmonomers. Additionally, the enzymat-
ic activity on nucleobase and nucleoside analogs was tested,
revealing the capability of TtPyNP to accept thymine, uracil,
and 2,4-dioxopyrimidines as substrates. The enzymatic activ-
ity towards arabinosyl nucleosides was found to be signif-
icantly lower than for 2′-deoxyribonucleosides (e.g., 55%
of conversion was reached when 2′-deoxyuridine is used as
donor, whereas 3% was obtained from arabinosyl uracil).
In addition, TtPyNP was not active against 3′ and 5′
substituted nucleosides, such as 3-azido-5-phosphoribose,
probably due to inadequate fitting of the pentose moiety
into the active site. Finally, TtPyNP did not recognize py-
rimidine ring substitutions at position 6, while the reaction
proceeded for some 5-substituted derivatives (e.g., 5-
iodoracil) (Fig. S1). Therefore, this lack of stringency on
position 5 can account for its capacity to accept both uracil
and thymine as substrates. As TtPyNP is active on 5-
iodouracil, 2,6-diaminopurine, and arabinosides, it could
be applied to the synthesis of nucleoside analogs used for
the treatment of human diseases (Almendros 2012).
In 2012, Szeker et al. (2012) performed the cloning, pro-
duction, and purification of PyNPs phosphorylases from T.
thermophilus (TtPyNP) and G. thermoglucosidasius
(GtPyNP). Although both enzymes displayed high thermal
stability, TtPyNP is clearly more thermostable than GtPyNP,
exhibiting a half-life of more than 24 h when stored at 80 °C.
In addition, kinetic analyses on both enzymes revealed similar
KM and kcat values for uridine phosphorolysis. In contrast,
TtPyNP showed a kcat value eight times higher than that of
GtPyNP when thymidine was used as the substrate. In addi-
tion, to evaluate the potential of both enzymes as industrial
biocatalysts, their ability to catalyze the phosphorolytic cleav-
age of several 2′-fluoro-2′-deoxynucleoside analogs was test-
ed. In light of the results obtained, TtPyNP could be used in
combination with a PNP for the synthesis of valuable APIs,
such as 2′-fluoro-2′-deoxyguanosine.
More recently, Zhou et al. (2015a) used a multi-enzymatic
approach for synthesizing several 2,6-dihalogenated nucleo-
side analogs, such as 2′-deoxynucleosides 2-chloro-2′-
deoxyadenosine (cladribine), 2-fluoro-2′-deoxyadenosine,
2,6-dichloro-2′-deoxyriboside and 2,6-diaminopurine-2′-
deoxyriboside, or the arabinosyl nucleosides ara-2,6-
diaminoupurine and ara-2,6-dichloropurine, among others.
The co-immobilization of TtPyNP and PNP from G.
thermoglucosidasius (GtPNP) on MagReSyn® epoxide-
activated spheres also led to an easy recovery of the
biocatalysts. Finally, as a proof of concept, the enzymatic syn-
thesis of 2,6-dichloro-2′-deoxyriboside was successfully
scaled up in a reaction volume of 50 mL with an overall
60% yield.
In 2015, the production of 2,6-dihalogenated purine nucle-
osides was performed through the same multi-enzymatic cas-
cade system TtPyNP/GtPNP (Zhou et al. 2015b). For that
purpose, the authors co-immobilized TtPyNP andGtPNP onto
epoxy-activated magnetic microspheres and optimized certain
immobilization and operational parameters (e.g., pH and tem-
perature, enzyme loading, binding time, reaction time, ther-
mostability, and substrate ratio). Finally, they applied TtPyNP/
GtPNP to the enzymatic production of some 2,6-
dihalogenated purine nucleosides with high conversion per-
centages (78.5–85.5%) and productivities (1.5–2.0 g/L/h).
In another sequential synthetic scheme, the enzymatic syn-
thesis of 2,6-diaminopurine nucleoside and 5-methyluridine
was performed using two thermostable NPs from Aeropyrum
pernixK1 (ApUP and ApPNP). Both enzymes (i) were shown
to be active and stable at extremely high temperatures (max-
imum activity at 90–100 °C), (ii) displayed negligible loss of
activity after being stored for 1 h at 90–100 °C) and in a broad
pH 4–9 range (activity > 80%), and iii) retained an activity >
60% when stored at pH 6–10 (Zhu et al. 2013).
Nucleoside 2′-deoxyribosyltransferases (NDTs)
Nucleoside 2′-nucleoside deoxyribosyltransferases (EC
2.4.2.6), also called N-deoxyribosyltransferases or trans-N-
deoxyribosylases, belong to the glycosyltransferases family,
as do NPs. NDTs catalyze the transglycosylation reaction of
the 2′-deoxyribose moiety between purine and/or pyrimidine
bases (Fresco-Taboada et al. 2013; Kaminski 2002) (Figs. 8
and 11). NDTs are key enzymes in the nucleobases salvage
pathway, being responsible for the recovery of both purine and
pyrimidine bases. In this regard, several protozoan and bacte-
rial NDTs have been reported (Bosch et al. 2006; Crespo et al.
2017; Del Arco et al. 2018b; Fernández-Lucas et al. 2010;
Fresco-Taboada et al. 2013, 2018; Kaminski 2002;
Lawrence et al. 2009; Méndez et al. 2018; Miyamoto et al.
2007; Steenkamp and Halbich 1992). NDTs can be classified
into two classes: type I NDTs (PDTs) specific for purines
(Pur↔Pur), such as adenine, guanine, or hypoxanthine, and
type II NDTs (NDTs), which catalyze the transfer of 2′-deoxy-
ribose among purines and/or pyrimidines (Pur↔Pur,
Pur↔Pyr, Pyr↔Pyr) (Fresco-Taboada et al. 2013; Kaminski
2002). These enzymes are strictly specific for 2 ′-
deoxynucleosides, regioselective (N-1 glycosylation in pyrim-
idine and N-9 in purine), as well as stereoselective (β-anomers
are exclusively formed). However, recent studies have shown
that NDTs are able to ribosylate in different positions of purine
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and pyrimidine rings (Fernández-Lucas et al. 2010; Fresco-
Taboada et al. 2013).
Despite the potential of NDTs as industrial biocatalysts,
only one thermophilic NDT has been described to date:
NDT from Chroococcidiopsis thermalis PCC 7203, CtNDT.
CtNDT is a homotetramer active on purine bases and 2′-
deoxynucleosides, but it also acts on cytosine and 2′-
deoxycytidine (Del Arco et al. 2018b). All of these unique
features prevent the strict classification of CtNDT into ei-
ther a type I or a type II NDT and further suggest that
oligomeric state and structure should complement and ex-
pand this functional classification in the future. Moreover,
CtNDT displays high activity values (80–100%) in the
presence of 20% of several water-miscible co-solvents,
such as ethyl acetate, acetone, acetonitrile, chloroform,
DMF, DMSO, methanol, ethanol, 2-propanol, ethylene
glycol, glycerol, and propylene glycol. CtNDT also
displayed activity and stability at a wide range of acid-
neutral pH values (from 3 to 7) and high temperatures
(from 50 to 100 °C). Finally, as a proof of concept, the
enzymatic synthesis of several therapeutic nucleosides,
such as arabinosyl adenine (vidarabine), arabinosyl cyto-
sine (cytarabine), 2′,3′-dideoxyinosine (didanosine), and
2′-fluoro-2′-deoxyguanosine, was carried out by CtNDT
(Fig. 11) (Fig. S1).
Uracil phosphoribosyltransferases (UPRTs)
UPRTs catalyze the reversible transfer of the 5-phosphoribosyl
group from PRPP to the N1 of uracil, in the presence of Mg2+
(Fig. 12). Since uridine-5′-monophosphate, UMP, is a common
precursor of all pyrimidine nucleotides, UPRT plays a key role
in the pyrimidine salvage pathways (Del Arco and Fernández-
Lucas 2017, Del Arco et al. 2017a). This enzyme displays a
marked preference for uracil and its derivatives, recognizing
neither thymine nor cytosine as substrates (Del Arco and
Fernández-Lucas 2017; Del Arco et al. 2017a). These enzymes
display great potential as biocatalysts; however, the high cost
and low stability of PRPP hinders their industrial application.
Several thermophilic UPRTs have been described, such
as dimeric UPRT from Bacillus caldolyticus, tetrameric
UPRTs from S. solfutaricus, Aquifex aeolicus, and T.
thermophilus (Del Arco et al. 2017a). Among them, we
wish to highlight the thermal activity and stability of
UPRTs from B. caldolyticus (relative activity ≈ 60% at
70 °C for 10 min), Sulfolobus shibatae (negligible loss of
activity at 80 °C for 1 h), and T. thermophilus (negligible
loss of activity at 70 °C for 4 h and a half-life over 70 min
at 80 °C) (Del Arco et al. 2017a).
Del Arco et al. (2017a) characterized the UPRT from T.
thermophilus, TtUPRT. As expected, the enzyme showed
great activity and stability across broad ranges of temper-
ature (from 50 to 80 °C), pH (from 5.5 to 9), and ionic
s t rength ( f rom 0 to 500 mM sodium chlor ide) .
Interestingly, substrate specificity studies revealed that
TtUPRT is active towards thymine, 5-halogenated uracil
derivatives, 5-hydroxymethyluracil, and 6-methyluracil
(Fig. S1). This report described for the first time the appli-
cation of an UPRT to the synthesis of therapeutic nucleo-
tide analogs, such as 5-bromouridine-5′-monophosphate,
5-chlorouridine-5′-monophosphate, 5-iodouridine-5′-
monopho spha t e , 5 - hyd roxy -me t hy l u r i d i n e - 5 ′ -
monophosphate, and 6-methyluridine-5′-monophosphate.
Fig. 11 Enzymatic synthesis of
nucleoside analogs by CtNDT
Fig. 12 Enzymatic production of pyrimidine nucleoside-5 ′-
monophosphate analogs by TtUPRT
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Due to its ability to act on 5-substituted pyrimidines (a
position commonly substituted in nucleotide analogs used
for the treatment of human diseases), TtUPRT could be ap-
plied to cancer treatment through the so-called suicide gene
therapy, based on the introduction into cancer cells of the
genes encoding cytosine deaminase (CD) and UPRT.
Conclusion
Purine and pyrimidine salvage enzymes are very interesting
biocatalysts for the synthesis of nucleoside and nucleotide
analogs. They can complement or replace other less efficient
and non-environmentally friendly synthetic strategies.
Enzymes from thermophiles are active and stable under ex-
treme temperatures, broad pH ranges, and the presence of
organic solvents. Because of this, the search for thermozymes
is a primary focus of interest in many biotechnological firms
and academic research groups. We hope that this mini-review
will help other scientists to appreciate the potential of thermo-
philic purine and pyrimidine salvage enzymes as biocatalysts
for the industrial production of nucleic acid derivatives.
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